2 13 relationship between local dose and toxicity is expected to be very informative, as it may be instrumental in identifying subregions at a higher risk of damage and thus facilitate the definition of more accurate dose-organ constraints.
The notion of spatial local dose variability and its relationship with toxicity have been already addressed in a limited number of works (Kupchak et al., 2008) , either using a parametric description of the dose distribution (Buettner et al., 2009 (Buettner et al., , 2011 or, for the first time, a voxel-based approach (Heemsbergen et al., 2010; Witte et al., 2010) , although with approximations in terms of both anatomical matching and dose mapping. In these two voxel-wise studies, which were focused on urinary tract toxicity (Heemsbergen et al., 2010) and prostate tumor control (Witte et al., 2010) , the dose mapping was mainly based on the radially-computed distances from the organ delineations.
These results provided the way forward for complex voxel-based toxicity models based on more accurate inter-individual matching. In order for voxel-wise comparisons to be meaningful, the doses must be accurately mapped to a common coordinate system, which is a challenging task due to the difficulties related to high inter-individual variability.
In response to the lack of spatial information of DVH-based predictive models, this paper proposes a new framework allowing the underlying relationship between local dose and toxicity to be analyzed across a population. This approach permits the identification of subregions within the critical organs, which may present a higher risk of damage and likely be responsible for toxicity. As depicted in Figure 1 , the proposed framework combines a precise anatomical non-rigid registration approach for mapping the population 3D dose distributions to a single coordinate system and a voxel-wise analysis with respect to toxicity. The proposed model yields a 3D map ( ), Φ x x , which may be seen as a 3D NTCP cartography, depicting regions where the dose differences between two groups are statistically ∈ ℝ 3 significant.
Materials and Methods
The main steps of the method are described in Figure 1 : i) the inter-individual CT and contour delineations are non-rigidly registered (NRR) into a common coordinate system (common template) using organ-to-organ constraints; ii) the planned dose distributions are mapped to the template by applying the computed transformations (dense deformation field ,); iii) voxel-wise comparison of the D⃗ mapped doses is performed (in this work, two-sampled t-tests for hypothesis testing). The resulting 3D images represent the dose differences between two groups and allow for the highlighting of voxels where those differences are statistically significant.
Patients, treatment and rectal toxicity
A total of 105 patients were included in the study, all having undergone IMRT for localized prostate cancer between July 2006 and June 2010 in the same institution. The target volume involved the prostate and seminal vesicles, without any lymph nodes. The total prescribed dose was 46Gy to the seminal vesicles delivered in 4.6 weeks, and 80Gy to the prostate delivered in 8 weeks, with a standard fractionation of 2Gy/fraction. The whole treatment (patient positioning, CT acquisition, and volume delineations) and dose constraints complied with GETUG 06 recommendations, as previously reported (Beckendorf et al., 2011) . In particular, the constraints for the rectal wall were maximal dose 76Gy and V72 Gy 25 . The size of the planning CT images in the axial plane was 512 512 pixels, with 1mm
image resolution, and 2mm slice thickness. The used treatment planning system was Pinnacle V7.4 (Philips Medical System, Madison, WI). Each treatment plan used five field beams, in a step-and-shoot delivery configuration with gantry angles of 260 , 324 textdegree, 36 ,°°1 00 and 180 . The delivery was guided by means of an IGRT protocol, with cone beam CT images or two orthogonal images (kV or MV°°i maging devices), using gold fiducial markers in 57 of patients.
%
The median follow-up period was 38 months, with a minimum of 24 months for all patients. Rectal toxicity events were prospectively collected, as all of the patients participated in one of two randomized trials, either the GETUG 14 (testing the benefit of 4-month androgen deprivation in addition to receiving 80Gy of radiation to the prostate) or the STIC-IGRT (testing the benefit of IGRT) (De Crevoisier et al., 2009 ). Rectal toxicity was scored according to the common terminology criteria for adverse events (CTCAE) version 3.0. The endpoint of the study was 2-year Grade 1 rectal bleeding, excluding acute toxicity. Patients with a history of hemorrhoids were not allowed to be 3 13 individuals. Thus, intensity-based similarity metrics may define the distance between individuals (Aljabar et al., 2009) . Given an adequate inter-individual similarity, the strategy may further include a clustering step aimed to identify the average individual that best represents the population (Ramus and Malandain, 2010) .
In this study, a typical individual was selected from the database in order to define the template. This individual was found by affinity propagation clustering (Frey and Dueck, 2007 )among a subgroup of randomly selected patients from the whole database. During the clustering step, the template emerged as the exemplar, which represented the individual closest to all of the remaining individuals. The considered inter-individual similarity criteria were the sum of squared differences (SSD) computed after rigid registration between individuals and I I
( 1) where is the number of voxels in the CT scans and represents the pelvic region where the computation was performed. 
Registration
Registering inter-individual CTs is particularly challenging due to the poor soft-tissue contrast, large inter-individual variability, and differences in bladder and rectum filling (Acosta et al., 2011) . Given this inter-individual anatomical matching, pure intensity-based registration was shown to be not accurate enough to meet the requirements for population analysis, possibly leading to non-negligible local errors (Drean et al., 2011) . However, if all the complementary information pertaining to the individual s anatomy was used, the registration ' s performance would improve considerably. We propose herewith an organ-driven non-rigid registration strategy built from the demons ' algorithm (Thirion, 1998), which yields an accurate match between organs in the common coordinate system (CS). This non-rigid registration approach advantageously exploits information available at the planning stage, namely the 3D anatomical data, 3D organ delineations, and planned doses as summarized in Fig. 3 
scans, replacing the original organ delineations; iv) the demons algorithm (Thirion, 1998) was finally used to non-rigidly register to .
I I
These constituted additional anatomic constraints, which facilitated the anatomic matching process. The use of Euclidean distance NL O k maps from organ surfaces reinforced accurate matching of doses close to the boundaries where pure intensity-based CT registration would fail. The result of this registration step was a dense deformation field ( ), which was then used to propagate the dose as shown in Fig. 4 .
D⃗ x

Dose propagation
The deformation field ( ), obtained in the previous step, is a set of 3 vectors defined at each voxel ( Fig. 4 ), thereby providing a D⃗ x D non-linear transformation to be applied to the dose distributions.
The doses were eventually propagated into the template by applying ( ) to each voxel position and sampled again in the space of D⃗ x ∈ I using tri-linear interpolation. Figure 5 shows an example of dose propagated from an individual towards the template. I
Scores for validation of registration and dose mapping
Different parameters were used in order to assess the quality of the dose mapping. These parameters validated both the accuracy of organ overlap after non-rigid registration as well as the coincidence of doses between the native and common coordinate systems.
Regarding registration, the Dice similarity coefficient (DSC) and Hausdorff distance (H) were used. The DSC (Zijdenbos et al., 1994 ) is defined as: (2) where is the intersection between each individual s registered rectum and the rectum of the template . This score ranges from 0 to between two sets of points or surfaces 1 , , 1 and 2 , , 2 as:
(3) where (4) and || || is the euclidean distance between the and points. The calculation ( , ) identifies the point 1 that is farthest
from any point of and measures the distance from 1 to its nearest neighbor in using || ||. This means that ( , ) ranks each
point of based on its distance to the nearest point of , and then uses the largest ranked point as the distance (Huttenlocher et al.,
For the validation of dose coincidence between native and common spaces, in order to compare dose mapping accuracy, we implemented two scores pertaining to the relative difference of areas (RDA) of DVHs and dose-organ overlap (DOO).
The RDA assesses the differences in DVHs following dose mapping while considering the information in the template coordinate system. For a given individual, let be the DVH computed between the mapped dose and the non-rigidly registered rectum, and let be h 1 h 2 the DVH computed with the warped dose and the rectum of the template,
The RDA is normalized between 0 (when ) and 1 using the area under the DVH curve. The DVHs are expected to be h 1 = h 2 preserved following registration. Therefore, if RDA tends to zero, a DVH-based NTCP model would be similar, whether computed in the native space or the common coordinate systems.
The DOO is a score that measures the coincidence of both the organs and dose distribution in the common space following registration. This parameter is computed as follows: (6) where ( ) is the registered dose distributions at , computed on the union and intersection of both organs (template and registered).
D x x
The DOO penalizes the overlap errors within the higher gradients of dose. Conversely, if the overlap is measured in a region of homogeneous dose, the score is the same as the Jaccard similarity metric (JAC), namely:
where represents the union of both and . Hence, the DOO ranges between 0 and 1, attaining the highest value when the dose on ∪ R R each voxel of both organs is the same.
Voxel-based Analysis
Statistical voxel-based comparisons are instrumental in detecting regional changes between groups by locally computing the difference of a signal across a given population (Friston KJ et al., 1995) . Different examples were reported in the literature, such as voxel-based morphometry (VBM) (Ashburner and Friston, 2000) , which allow the differences related to density changes in a given tissue, such as gray matter changes in the brain on account of a disease, to be assessed (Yuan et al., 2008) . These differences may reflect local anatomical changes, such as tensor-based morphometry (Hua et al., 2008; Leow et al., 2007) , the analysis of which relies on Jacobian images obtained by warping individual data to a common template. Some studies have combined hypometabolism and atrophy using positron emission tomography (PET) images, where the differences may be accounted for by functional integrity (Ch telat et al., 2008; Desgranges et al., é 2007).
In our study, the signals to be compared on a voxel level were the 3D planned dose distributions across the population. Two groups were therefore constituted, namely individuals with rectal bleeding those with no rectal bleeding, according to the inclusion criteria versus described in section 2.1. In order for the voxel-wise comparisons to be meaningful, only accurately registered rectum data was included.
Registration accuracy was measured as a high-volume overlap (Dice score >0.7) between the rectum in template space and NRR individuals. As a result, two groups were obtained, comprising 51 non-bleeding and 12 bleeding subjects, respectively. Voxel-wise two-sampled t-tests were performed, resulting in 3D maps for both dose differences and p-values. The regions exhibiting statistically 5 13 significant between-group differences (p <0.01) were characterized in terms of absolute volume, mean dose difference, and rectal localization in the rectum, more precisely distance of the region to the prostate and seminal vesicle surfaces. Fig. 5 depicts an example of the dose mapping from the individual s native coordinate system to the template coordinate system using ' the proposed framework.
Results
Considering the whole population, the average dice score for the rectum was 0.75 0.12 and the Hausdorff distance 28.17 16, ± mm ± while the DOO and the RDA were 0.64 0.1 and 0.09 0.05, respectively.
± ± Figure 6 depicts the between-group dose differences in the rectum. The dose prescribed to patients with rectal bleeding was significantly higher (6.43Gy, p<0.01) in a small portion of the rectum (labeled R1). Figures 6(b) and 6(c) show lateral and coronal views of the 3D reconstructed common template highlighting the region R1. This 3184.06 region, located in the anterior wall and mm 3 middle-third of the rectum, represented 9.11 of the total rectal volume.
% Table 1 characterizes the distribution of statistically significant voxels (region R1) with respect to the distance to the prostate and seminal vesicles surfaces. 35 .86 of R1 was within the first 5mm, receiving in average 4.55 Gy more within the rectal bleeding patients % but more than 90 of R1 was located within the first centimeter (anterior wall). This result shows that the more sensitive area was within % the first 10 to 15mm, and that within this region, the average dose delivered to rectal bleeding patients was exceeded by 6.40Gy as + compared to that delivered to non-bleeding patients. Figure 7 shows the averaged DVHs within R1, compared with the DVHs computed for the whole rectum. Inside R1, the differences between bleeding and non-bleeding patients were between and , reaching statistical significance ( 0.01), as opposed to V 40 Gy V 66 Gy p < the whole rectum where no significant differences were found.
Discussion
The particular novelty presented here, in comparison with traditional DVH-based models, makes maximal use of 3D dose distributions, resulting in a correlation between local toxicity and local planned dose. The proposed method relies on an accurate non-rigid registration strategy allowing the dose distributions across a population to be mapped and compared on a common coordinate system. The voxel-wise analysis would permit the identification of subregions within the organs at risk, which may be responsible for secondary effects, hence highlighting heterogeneous intra-organ radio-sensitivity.
The Grade 1 bleeding toxicity was chosen as the main endpoint in this study, as such events are relatively frequent when high-dose ≥ is delivered to the prostate (approximately 20 after 2 years) allowing for statistical tests to be performed. In addition, rectal bleeding is a % symptom that can be relatively objectively reported (excluding patients with a history of hemorrhoids). Moreover, most of the studies assessing NTCP models for rectal toxicity are focused on rectal bleeding.
Based on our results, the anterior part of the rectal wall correlated with rectal bleeding. This region, representing less than 10 of the % whole rectum, was given 6Gy more, on average, in bleeding patients and was mainly located within the first 15mm, close to where high-dose was delivered to the prostate. In addition, the average DVH computed within this region allowed for better separation between both groups, resulting in a clear volume effect (Fig. 7) .
These results are in line with the Lyman-Kutcher-Burman NTCP model studies, which reported effective volume values (often denoted by ) between 0.06 and 0.13 for moderate/severe bleeding, thus highlighting the high-dose range impact and suggesting that the n rectum was a prevalently serial organ. Indeed, in our study, a small non circumferential volume within the anterior part of the rectum was found to be correlated with rectal bleeding (grade> 1). However, the intermediate doses inside this rectal region better discriminate
bleeders from non-bleeders, as it is discussed in (Rancati et al., 2004) . Nevertheless, results from the literature as well as from our voxel-based comparison study must be interpreted with caution, taking into account several RT parameters. These results depend on the ability of the conformal technique to spare the posterior part of the rectum from intermediate dose levels (40Gy to 50Gy), total dose " " prescribed in the prostate, and dose volume constraints in the rectum, potentially allowing a high-dose to be delivered to the anterior rectal wall. The observation that the anterior part of the rectum appears to be involved in rectal bleeding equally corresponds to the clinical experience of rectal cauterization. This finding is in line with a report on a series of 44 patients who voluntarily accepted to undergo flexible rectosigmoidoscopy. In this investigation, the occurrence of telangiectasia increased from the posterior to the anterior rectal wall, and Grade 3 telangiectasia was exclusively limited to the high-dose region of the anterior rectal wall (Wachter et al., 2000) .
Nevertheless, it should be noted that the toxicity results must be carefully considered in terms of cause-effect relationships. We are depicting regions that are correlated with toxicity, which are not necessarily responsible for it. New cohorts of patients are required in 6 13 order to validate the hypothesis raised by means of this voxel-based approach. New findings in terms of dose-toxicity relationships may appear for other symptoms. Larger series of patients would allow for a multivariate analysis to be performed, taking into account patient-specific characteristics in addition to the treatment parameters. Other organs should also be explored, such as the bladder, where most of the models have not found any dose-effect relationship.
Another key point to take into account is the potential difference between the planned and actual delivered doses. In effect, in the course of the treatment, the organs at risk may deform or displace with respect to the initial conditions at the planning step. This is also an issue for the current NTCP models that consider only planned dose distributions. In our study, however, more than half of the included patients were treated following an IGRT protocol, which likely minimizes the impact of anatomical variations, at least to some extent. The next generation of NTCP models should ideally be established on both planning imaging, as well as imaging acquired during each fraction.
This issue is currently being tackled in further works, where dose-tracking strategies may help improve accuracy. In addition, statistical approaches are being developed so as to model these uncertainties (S hn et al., 2005) , considering the actual delivered dose as a random ö variable, while investigating the impact of the deformations on toxicity outcome.
The proposed framework, as depicted in Figure 1 , relies on a non-rigid matching of organs and CT scans. The use of Euclidean distance maps from organ boundaries allowed for accurate matching of doses close to the rectal wall. Additionally, further registration approaches are being investigated to improve the aligning of different structures. A combined CT-organ registration with a spatial weighted function was recently proposed (Drean et al., 2012) , but still needs to be validated within this framework.
Another point to be investigated in future research is the optimal template selection. Different strategies exist to select a template from a database to be representative of a given population. In some applications, an average individual may be obtained by iteratively registering and computing intensity means (Rohlfing et al., 2004) . Other approaches are based on group-wise registration (Wachinger and Navab, 2012). In our clustering strategy, we selected a single representative individual, however, more clusters may also be selected in order to reproduce the voxel-wise analysis on different templates (Rohlfing et al., 2009) . The question brought to mind is therefore the computation of inter-individual similarities, which may be tackled, as already done in the past within the scope of atlas based segmentation (Rohlfing et al., 2004; Wu et al., 2007) .
Concerning the voxel-based statistical dose analysis, we are considering other alternative approaches that take into account the effect of individuals, in line with the non-parametric mixed-effect model proposed by (Ospina et al., 2011 (Ospina et al., , 2012 . This method, which exploits intra-individual spatial correlation at each voxel location, can handle more efficiently large variances between groups. Preliminary results demonstrated an improved sensitivity and reliability for group analysis, as compared with standard voxel-wise methods. One interesting feature is the possibility of including clinical data or other confounding variables within the formulation. A similar method that is currently being explored is the dimensionality reduction of data (Chen et al., 2011) in order to extract the main spatial features of the 3D dose distributions, which would allow patients to be classified in two groups.
Determining the heterogeneous intra-organ sensitivity across a population, combined with patient-specific information in an inverse IMRT planning, may allow for the production of personalized treatment with high local control and reduced toxicity, as observed in other studies with different constraints (S hn, Yan, Liang, Meldolesi, Vargas and Alber, 2007) . This general scope may be extended in order to Wachter S , Gerstner N , Goldner G , P tzi ö R , Wambersie A , P tter ö
Figure 1
General framework of the proposed dose mapping and voxel-wise analysis. The anatomical information from a patient is NRR registered to a common template. The result is a vector field , which is used later on for dose mapping. D⃗ 
Figure 3
The hybrid non-rigid registration (NRR) approach, bringing 3D doses from their native coordinate system (CS) to the common CS. After organ delineation, normalized distance maps (NDMAPS) are computed and combined with the CT scan to be registered. The result is the transformation (deformation field) used to map the dose
Figure 4
Example of the resulting transformation (deformation field, D) used to map the dose
Figure 5
Example of 3D non-rigid dose mapping using the computed transformation from Results of voxel-wise analysis in the template space for rectal bleeding. a) Mean differences in dose between the two groups. b, c) 3-dimensional reconstruction of a) lateral and b) coronal views of the common template, highlighting the rectal region R1, where these differences were statistically significant (p< 0.01). In our study, this region represented less than 10 of the whole rectum and appears close % to the prostate in the anterior rectal wall
Figure 7
Averaged dose-volume histogram comparison for the two groups. They were computed in the rectum and in R1. The DVH for R1 allowed for the segmentation of a subregion within the rectum, which correlated with rectal bleeding. In addition, the DVHs in R1 were significantly different ( < 0.01) 
